Next Article in Journal
Correction: Graillot, B.; et al. Progressive Adaptation of a CpGV Isolate to Codling Moth Populations Resistant to CpGV-M. Viruses 2014, 6, 5135–5144
Next Article in Special Issue
Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy
Previous Article in Journal
Alphacoronaviruses Detected in French Bats Are Phylogeographically Linked to Coronaviruses of European Bats
Previous Article in Special Issue
Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants
Article Menu

Export Article

Open AccessReview
Viruses 2015, 7(12), 6291-6312; doi:10.3390/v7122938

Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?

Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS2 9JT, UK
Author to whom correspondence should be addressed.
Academic Editors: Martine Lamfers and E. Antonio Chiocca
Received: 24 September 2015 / Revised: 20 November 2015 / Accepted: 25 November 2015 / Published: 2 December 2015
(This article belongs to the Special Issue Oncolytic Viruses)
View Full-Text   |   Download PDF [263 KB, uploaded 2 December 2015]


The last few years have seen an increased interest in immunotherapy in the treatment of malignant disease. In particular, there has been significant enthusiasm for oncolytic virotherapy, with a large amount of pre-clinical data showing promise in animal models in a wide range of tumour types. How do we move forward into the clinical setting and translate something which has such potential into meaningful clinical outcomes? Here, we review how the field of oncolytic virotherapy has developed thus far and what the future may hold. View Full-Text
Keywords: oncolytic virus; immunotherapy; reovirus; vaccinia; HSV; clinical trials oncolytic virus; immunotherapy; reovirus; vaccinia; HSV; clinical trials
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Turnbull, S.; West, E.J.; Scott, K.J.; Appleton, E.; Melcher, A.; Ralph, C. Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going? Viruses 2015, 7, 6291-6312.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top